ALK c.1606_1608delinsGAG ;(p.S536E)

Variant ID: 2-29541209-ACT-CTC

NM_004304.4(ALK):c.1606_1608delinsGAG;(p.S536E)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer.

Cell Reports
Blakely, Collin M CM; Pazarentzos, Evangelos E; Olivas, Victor V; Asthana, Saurabh S; Yan, Jenny Jiacheng JJ; Tan, Irena I; Hrustanovic, Gorjan G; Chan, Elton E; Lin, Luping L; Neel, Dana S DS; Newton, William W; Bobb, Kathryn L KL; Fouts, Timothy R TR; Meshulam, Jeffrey J; Gubens, Matthew A MA; Jablons, David M DM; Johnson, Jeffrey R JR; Bandyopadhyay, Sourav S; Krogan, Nevan J NJ; Bivona, Trever G TG
Publication Date: 2015-04-07

Variant appearance in text: ALK: S536E
PubMed Link: 25843712
Variant Present in the following documents:
  • Main text
View BVdb publication page